Multiple Sclerosis patients carry an increased burden of exceedingly rare genetic variants in the inflammasome regulatory genes

• Published in: Scientific reports Vol. 9; no. 1; pp. 9171 - 10
• Main Authors: Vidmar, Lovro, Maver, Ales, Drulović, Jelena, Sepčić, Juraj, Novaković, Ivana, Ristič, Smiljana, Šega, Saša, Peterlin, Borut
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 24.06.2019; Nature Publishing Group
• Subjects: 45/23; 631/208; 631/208/514/2254; Adult; Autoimmune diseases; Autophagy; Cohort Studies; DNA viruses; Etiology; Female; Genes, Regulator; Genetic diversity; Genetic Predisposition to Disease; Genetic variance; Humanities and Social Sciences; Humans; Immune system; Inactivation; Inflammasomes; Inflammasomes - genetics; Innate immunity; Male; multidisciplinary; Multiple sclerosis; Multiple Sclerosis - genetics; Mutation; Pathogenicity; Pathogens; Phagocytosis; Regulation; Science; Science (multidisciplinary); Signal transduction; Tyk2 protein; Whole Exome Sequencing; β-Interferon
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-019-45598-x

The role of rare genetic variation and the innate immune system in the etiology of multiple sclerosis (MS) is being increasingly recognized. Recently, we described several rare variants in the NLRP1 gene, presumably conveying an increased risk for familial MS. In the present study we aimed to assess rare genetic variation in the inflammasome regulatory network. We performed whole exome sequencing of 319 probands, comprising patients with familial MS, sporadic MS and control subjects. 62 genes involved in the NLRP1/NLRP3 inflammasome regulation were screened for potentially pathogenic rare genetic variation. Aggregate mutational burden was analyzed, considering the variants’ predicted pathogenicity and frequency in the general population. We demonstrate an increased (p = 0.00004) variant burden among MS patients which was most pronounced for the exceedingly rare variants with high predicted pathogenicity. These variants were found in inflammasome genes (NLRP1/3, CASP1), genes mediating inflammasome inactivation via auto and mitophagy (RIPK2, MEFV), and genes involved in response to infection with DNA viruses (POLR3A, DHX58, IFIH1) and to type-1 interferons (TYK2, PTPRC). In conclusion, we present new evidence supporting the importance of rare genetic variation in the inflammasome signaling pathway and its regulation via autophagy and interferon-β to the etiology of MS.